Suppr超能文献

焦磷酸盐和双膦酸盐可抑制无定形磷酸钙介导的基质金属蛋白酶-9与纤维蛋白的结合。

Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

作者信息

Makowski G S, Ramsby M L

机构信息

Department of Laboratory Medicine, University of Connecticut Health Center, Farmington 06030-2235, USA.

出版信息

Inflammation. 1999 Aug;23(4):333-60. doi: 10.1023/a:1020209616428.

Abstract

Coordinate regulation of fibrinolytic and collagenolytic systems is essential for normal tissue remodeling and wound healing. To define the molecular mechanisms which link these two proteolytic systems, we have investigated the role of fibrin in matrix metalloproteinase (MMP) function. Both active and latent forms of MMP-9 (gelatinase B) bind to fibrin in a selective, dose-dependent manner; latent enzyme is activated by plasmin during fibrinolysis. Fibrin binding of MMP-9 is mediated by amorphous calcium phosphate (ACP), and proceeds in a step-wise fashion with formation of ACP as the first and rate-limiting step. MMP-9 rapidly binds preformed ACP to yield a transient ACP: MMP-9 complex that avidly binds fibrin. Here we report the effect(s) on fibrin: ACP: MMP-9 formation/dissociation of pyrophosphate (POP), an endogenous calcification inhibitor, and its bisphosphonate analog, alendronate (PCP). MMP-9 was obtained from neutrophil lysate and ACP formation was monitored turbidimetrically. Free MMP-9, ACP: MMP-9 and fibrin: ACP: MMP-9 complexes were analyzed by gelatin zymography. POP at physiologic concentrations (0.5-2.5 microM) inhibited both ACP formation and subsequent fibrin binding of MMP-9 at orthophosphate concentrations of 250 microM. PCP exhibited a similar inhibitory effect. With both substances, inhibition was slightly overcome (>2.5 microM) by higher phosphate (500 microM). In contrast, supraphysiologic concentrations of either POP or PCP (>50 microM) were required to inhibit MMP-9 binding to preformed ACP or to induce dissociation of preformed ACP: MMP-9 complexes (50-100 microM). Neither POP nor PCP had any effect on preformed fibrin: ACP: MMP-9 at concentrations up 1 mM. POP is an endogenous by-product of numerous metabolic pathways and may regulate bone turnover, soft tissue calcification, and contribute to the pathogenesis of calcium pyrophosphate crystal disease (CPPD). These studies support another role for POP and fibrin: ACP: MMP-9 complexes in physiologic and pathologic processes, including tumorigenesis and cancer metastasis.

摘要

纤维蛋白溶解系统和胶原溶解系统的协同调节对于正常组织重塑和伤口愈合至关重要。为了确定连接这两个蛋白水解系统的分子机制,我们研究了纤维蛋白在基质金属蛋白酶(MMP)功能中的作用。活性和潜伏形式的MMP-9(明胶酶B)均以选择性、剂量依赖性方式与纤维蛋白结合;潜伏酶在纤维蛋白溶解过程中被纤溶酶激活。MMP-9与纤维蛋白的结合由无定形磷酸钙(ACP)介导,并以逐步方式进行,形成ACP是第一步且为限速步骤。MMP-9迅速结合预先形成的ACP,产生一个能强烈结合纤维蛋白的瞬时ACP:MMP-9复合物。在此我们报告内源性钙化抑制剂焦磷酸盐(POP)及其双膦酸盐类似物阿仑膦酸盐(PCP)对纤维蛋白:ACP:MMP-9形成/解离的影响。MMP-9从嗜中性粒细胞裂解物中获得,通过比浊法监测ACP的形成。通过明胶酶谱分析游离的MMP-9、ACP:MMP-9和纤维蛋白:ACP:MMP-9复合物。生理浓度(0.5 - 2.5 microM)的POP在正磷酸盐浓度为250 microM时,抑制ACP的形成以及随后MMP-9与纤维蛋白的结合。PCP表现出类似的抑制作用。对于这两种物质,较高的磷酸盐(500 microM)可略微克服抑制作用(>2.5 microM)。相反,需要超生理浓度的POP或PCP(>50 microM)来抑制MMP-9与预先形成的ACP的结合或诱导预先形成的ACP:MMP-9复合物的解离(50 - 100 microM)。在浓度高达1 mM时,POP和PCP对预先形成的纤维蛋白:ACP:MMP-9均无任何影响。POP是众多代谢途径的内源性副产物,可能调节骨转换、软组织钙化,并参与焦磷酸钙晶体疾病(CPPD)的发病机制。这些研究支持了POP以及纤维蛋白:ACP:MMP-9复合物在生理和病理过程(包括肿瘤发生和癌症转移)中的另一个作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验